Moreover, in our mixed cohort of intermediate and high-grade sarcomas, PRAME expression was prognostic for unfavourable survival, which was not the case in the studies of liposarcoma, leiomyosarcoma, and synovial sarcoma subgroups by others [9,22]. This evidence concerns the gene PRAME and liposarcoma.